Our pharmacology team has extensive drug discovery and development experience in the pharmaceutical industry enabling us to support fully integrated programs, including study design and data interpretation. By working together closely, our chemists, discovery biologists, and drug metabolism and pharmacokinetics (DMPK) scientists are able to provide BioDuro clients a range of flexible service models including integrated programs, full time employee (FTE) services or fee-for-services (FFS).
BioDuro’s pharmacology team currently focuses on metabolic diseases including diabetes and obesity, oncology, CNS and inflammatory diseases, etc. In addition, our team’s broad background in biomedical research allows us to successfully establish a wide range of diseases/disorders such as osteoporosis, hematopoiesis, cachexia and cardiovascular diseases.
New capabilities enhance our on-site animal facility, which is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)
Back To Top
Copyright © 2015 BioDuro, LLC